Application of hydrogen-bond propensity calculations to an indomethacin–nicotinamide (1 : 1) co-crystal†
Abstract
The crystal structure of an indomethacin–nicotinamide (1 : 1) co-crystal produced by
* Corresponding authors
a
Pharmaterials Ltd., Unit B, 5 Boulton Road, Reading RG2 0NH, UK
E-mail:
mridul.majumder@pharmaterials.co.uk
Fax: +44 (0)1189 310679
Tel: +44 (0)1189 209900
b School of Pharmacy, University of Reading, Whiteknights, Reading RG6 6AD, UK
c UCL School of Pharmacy, 29–39 Brunswick Square, London WC1N 1AX, UK
d Bristol-Myers Squibb Pharmaceuticals Limited, Reeds Lane, Moreton, CH46 1QW, UK
e Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK
The crystal structure of an indomethacin–nicotinamide (1 : 1) co-crystal produced by
M. Majumder, G. Buckton, C. F. Rawlinson-Malone, A. C. Williams, M. J. Spillman, E. Pidcock and K. Shankland, CrystEngComm, 2013, 15, 4041 DOI: 10.1039/C3CE40367J
To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.
If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.
If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content